ReviewFrontiers in neurology2019
Pre-hospital Assessment of Large Vessel Occlusion Strokes: Implications for Modeling and Planning Stroke Systems of Care.
Review in Frontiers in neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 33 citations in OpenAlex.
- Diagnostic Accuracy of the ACT-FAST Tool for Prehospital Stroke Identification: A Systematic Review.Archives of academic emergency medicine · 2026Review
- Perception of Quality of Life, Brain Regions, and Cognitive Performance in Hispanic Adults: A Canonical Correlation Approach.Clinical and translational neuroscience · 2025Article
- Machine Learning-Enabled Automated Large Vessel Occlusion Detection Improves Transfer Times at Primary Stroke Centers.Stroke (Hoboken, N.J.) · 2024Article
- Contribution of the 5G Smart First-Aid Care Platform to Achieving High-Quality Prehospital Care.Journal of medical Internet research · 2023Article
- FAST-ED scale for prehospital triage of large vessel occlusion: results in the field.Arquivos de neuro-psiquiatria · 2022Article
- Express improvement of acute stroke care accessibility in large regions using a centralized telestroke network.European stroke journal · 2022Article
- Progression of cerebral infarction before and after thrombectomy is modified by prehospital pathways.Journal of neurointerventional surgery · 2022Article
- Incidence, lethality, and post-stroke functional status in different Brazilian macro-regions: The SAMBA study (analysis of stroke in multiple Brazilian areas).Frontiers in neurology · 2022Article
- Adapting pre-hospital stroke triage systems to expanding thrombectomy indications.Neuroradiology · 2021Article
- From Three-Months to Five-Years: Sustaining Long-Term Benefits of Endovascular Therapy for Ischemic Stroke.Frontiers in neurology · 2021Review
- Pitfalls in the Diagnosis of Posterior Circulation Stroke in the Emergency Setting.Frontiers in neurology · 2021Review
- Addressing the Stroke Triage Challenge.Frontiers in neurology · 2021Article
- Research progress of pre-hospital emergency during 2000-2020: a bibliometric analysis.American journal of translational research · 2021Article
- Evaluation of Artificial Intelligence-Powered Identification of Large-Vessel Occlusions in a Comprehensive Stroke Center.AJNR. American journal of neuroradiology · 2021Article
- Extracellular Vesicles in Acute Stroke Diagnostics.Biomedicines · 2020Review
- Twenty Years of Cerebral Ultrasound Perfusion Imaging-Is the Best yet to Come?Journal of clinical medicine · 2020Review
- Optimizing Stroke Care for Patients with Large Vessel Occlusions: Current State of the Art and Future Directions.Journal of neuroendovascular therapy · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The social and financial burden of stroke is remarkable. Stroke is a leading cause of death and long-term disability worldwide. For several years, intravenous recombinant tissue plasminogen activator (IV rt-PA) remained as the only proven therapy for acute ischemic stroke. However, its benefit is hampered by a narrow therapeutic window and limited efficacy for large vessel occlusion (LVO) strokes. Recent trials of endovascular therapy (EVT) for LVO strokes have demonstrated improved patient outcomes when compared to treatment with medical treatment alone (with or without IV rt-PA). Thus, EVT has become a critical component of stroke care. As in IV rt-PA, time to treatment is a crucial factor with high impact on outcomes. Unlike IV rt-PA, EVT is only available at a limited number of centers. Considering the time sensitive benefit of reperfusion therapies of acute ischemic stroke, costs and logistics associated, it is recommended that regional systems of acute stroke care should be developed. These should include rapid identification of suspected stroke, centers that provide initial emergency care, including administration of IV rt-PA, and centers capable of performing endovascular stroke treatment with comprehensive periprocedural care to which rapid transport can be arranged when appropriate. In the pre-hospital setting, the development of scales easier and quicker to perform than the NIHSS yet with a maintained accuracy for detecting LVO strokes is of paramount importance. Several scales have been developed. On the other hand, the decision whether to transport to a primary stroke center (PSC) or to a comprehensive stroke center (CSC) is complex and far beyond the simple diagnosis of a LVO. Ongoing studies will provide important answers to the best transfer strategy for acute stroke patients. At the same time, the development of new technologies to aid in real time the decision-making process will simplify the logistics of regional systems for acute stroke care and, likely improve patients' outcomes through tailored selection of the most appropriate recanalization strategy and destination center.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.